Ascend Wellness Holdings (AAWH) Short term Debt (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Short term Debt came in at $9.8 million in Q1 2026, down 87.99% year-on-year from $81.4 million in Q1 2025, and down 5.67% quarter-over-quarter from $10.4 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Short term Debt (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Short term Debt history runs 7 years deep, the most recent figure standing at $9.8 million for Q1 2026.
- On a quarterly basis, Short term Debt fell 87.99% year-over-year to $9.8 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 87.99% decrease from a year earlier, with the FY2025 full-year figure at $10.4 million, down 85.74% from the prior year.
- Short term Debt declined to $9.8 million in Q1 2026 per AAWH's latest filing, from $10.4 million in the prior quarter.
- Across five years, Short term Debt topped out at $81.4 million in Q1 2025 and bottomed at $2.6 million in Q1 2023.
- The 5-year median for Short term Debt is $11.3 million (2022), against an average of $24.7 million.
- Across the five-year window, Short term Debt jumped 1257.24% in 2024 and plunged 87.99% in 2026, its largest moves.
- Year by year, Short term Debt stood at $11.3 million in 2022, then dropped by 28.5% to $8.1 million in 2023, then soared by 797.43% to $72.7 million in 2024, then slumped by 85.74% to $10.4 million in 2025, then fell by 5.67% to $9.8 million in 2026.
- Per Business Quant, the three latest AAWH Short term Debt figures stand at $9.8 million (Q1 2026), $10.4 million (Q4 2025), and $25.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.78 Mn |
| Dec 31, 2025 | 10.37 Mn |
| Sep 30, 2025 | 25.30 Mn |
| Jun 30, 2025 | 26.15 Mn |
| Mar 31, 2025 | 81.41 Mn |
| Dec 31, 2024 | 72.69 Mn |
| Sep 30, 2024 | 73.74 Mn |
| Jun 30, 2024 | 19.76 Mn |
| Mar 31, 2024 | 21.82 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 9.01 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 11.33 Mn |
| Sep 30, 2022 | 19.47 Mn |
| Jun 30, 2022 | 11.23 Mn |
| Mar 31, 2022 | 11.11 Mn |
| Dec 31, 2021 | 27.94 Mn |
| Sep 30, 2021 | 25.07 Mn |
| Jun 30, 2021 | 24.06 Mn |